Substance Use Disorders

Top Story

Current ADHD medications provide patients, clinicians with ‘exciting’ options

October 8, 2019
Meeting News

Lofexidine lowers need for supportive medications to control opioid withdrawal symptoms

October 7, 2019
Results from a study presented at Psych Congress suggested that lofexidine can effectively mitigate symptoms of opioid withdrawal syndrome during peak withdrawal —…
Meeting NewsVideo

Lofexidine, ketamine, cannabinoids: possible alternatives to opiates for chronic pain

October 5, 2019
SAN DIEGO — Thomas Kosten, MD, Waggoner Chair and Professor of Psychiatry, Pharmacology, Immunology, and Neuroscience, and director of the division of addictions…
Meeting NewsVideo

Clinical challenges in MDD patients with comorbid disorders

October 5, 2019
SAN DIEGO — In a video interview, W. Clay Jackson, MD, DipTh, clinical assistant professor of family medicine and psychiatry, University of Tennessee College of…
More Headlines »
CME Article

Considering Ketamine for Treatment of Comorbid Pain, Depression, and Substance Use Disorders

Psychiatric Annals, April 2018, Volume 48 Issue 4
The use of ketamine for treatment of comorbid pain, depression, and substance use disorders (SUDs) is becoming an…
More »
CME

Behavioral Health Issues in Adolescents: June 2019

AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals

More »
Video
Meeting News

Clinical challenges in MDD patients with comorbid disorders

October 5, 2019
More »
Healio Jobs